Lill-Brith Wium Von Arx

RWE Northern Europe Hub Lead, Senior Director Eli Lilly & Co.

Lill-Brith Von Arx, is an epidemiologist and pharma leader with over two decades of experience real-world evidence generation in health data landscaping. Her cross-border research in the UK & Nordics aligns on structuring data to drive healthcare innovation. A frequent speaker at RWE and industry summits, Lill-Brith advocates for quality driven and transparent use of real-world data.

Seminars

Wednesday 25th February 2026
Panel Discussion: Data Access in Practice: Building Sustainable, Ethical, & Scalable RWE Across Europe
12:00 pm
  • How can pharma, registries, and vendors collaborate to avoid duplication and improve efficiency in finding usable datasets?
  • What frameworks are needed to establish fair and transparent remuneration for physicians, patients, and database owners?
  • How do we balance sustainability of smaller registries with industry’s need for scale and interoperability?
  • How should pharma assess the risks of supporting new registries, and what funding and contracting models best incentivise long-term patient recruitment?
  • Where can AI and automation play a role in reducing healthcare system burden and improving data timeliness?
Wednesday 25th February 2026
Chair’s Opening Remarks
8:55 am
Lill-Brith Wium von Arx - 3rd IMPACCT Real World Evidence Summit Europe